Skip to content Skip to footer
Ustekinumab: Benefits, Reviews, Info, Side Effects!
Rx Details
Ustekinumab
Stelara, IL-12/IL-23 inhibitor
Ustekinumab
Prescription
Biologic
Drugs
Biologic
treatment of moderate to severe plaque psoriasis, treatment of active psoriatic arthritis, treatment of moderate to severe Crohn’s disease, treatment of moderate to severe ulcerative colitis, reduction of inflammation, improvement of skin lesions, improvement of joint symptoms, improvement of gastrointestinal symptoms
Back Pain, Diarrhea, Dizziness, Fatigue, Headache, Injection Site Reactions, Itching, Joint Pain, Nausea, Redness At The Injection Site, Sinus Infection, Sore Throat, Stomach Pain, Upper Respiratory Infections
Ustekinumab, marketed under the brand name Stelara, is a monoclonal antibody used to treat several autoimmune conditions, including psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. The dosage of ustekinumab can vary depending on the condition being treated and the patient’s weight. Here is a general guideline for its use: 1. **Plaque Psoriasis:** – **Adults:** An initial dose of 45 mg administered subcutaneously, followed by a 45 mg dose at week 4, and then every 12 weeks thereafter. For patients weighing more than 100 kg, the dose may be increased to 90 mg. 2. **Psoriatic Arthritis:** – **Adults:** The same dosing regimen as for plaque psoriasis, with 45 mg initially, followed by 45 mg at week 4, and then every 12 weeks. For patients over 100 kg, 90 mg may be used. 3. **Crohn’s Disease and Ulcerative Colitis:** – **Adults:** An initial intravenous infusion dose based on body weight (approximately 260 mg for patients ?55 kg, 390 mg for patients >55 kg to ?85 kg, and 520 mg for patients >85 kg). This is followed by a maintenance dose of 90 mg administered subcutaneously every 8 weeks. It’s important to note that these are general guidelines, and the exact dosage should be determined by a healthcare professional based on individual patient needs and response to treatment. Always consult with a healthcare provider for personalized medical advice.
Crohn’s disease, plaque psoriasis, psoriatic arthritis, ulcerative colitis
Generally well-tolerated with low risk of serious side effects.
No Interactions Reported
$1,000 – $5,000
$5,500 for a 1 syringe kit (45mg/05ml) of Stelara.

A Synopsis of

Ustekinumab

Ustekinumab is a medication that is commonly used to treat certain autoimmune conditions such as psoriasis and psoriatic arthritis. It works by targeting specific proteins in the body that are involved in the inflammatory response, helping to reduce symptoms and improve overall quality of life for patients.

This medication is typically administered as an injection either under the skin or into a vein, depending on the specific condition being treated. It is important to follow the dosing schedule provided by your healthcare provider to ensure optimal results.

As with any medication, there are potential side effects to be aware of when taking ustekinumab. These can include injection site reactions, headaches, and upper respiratory infections. It is important to discuss any concerns or side effects with your healthcare provider to determine the best course of action.

It is also important to inform your healthcare provider of any other medications or supplements you may be taking, as they can interact with ustekinumab and potentially cause adverse effects.

Overall, ustekinumab can be a highly effective treatment option for those suffering from autoimmune conditions such as psoriasis and psoriatic arthritis. By working with your healthcare provider to develop a personalized treatment plan, you can experience relief from symptoms and improve your overall quality of life.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN